Anavex Life Sciences
AVXL
56 hedge funds and large institutions have $22.5M invested in Anavex Life Sciences in 2019 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 13 increasing their positions, 15 reducing their positions, and 6 closing their positions.
117% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 6
115% more capital invested
Capital invested by funds: $10.5M → $22.5M (+$12M)
14% more funds holding
Funds holding: 49 → 56 (+7)
1.12% more ownership
Funds ownership: 14.42% → 15.54% (+1.1%)
13% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 15
92% less call options, than puts
Call options by funds: $74K | Put options by funds: $912K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$508K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$409K |
| 3 |
Barclays
London,
United Kingdom
|
+$281K |
| 4 |
BRF
B. Riley Financial
Los Angeles,
California
|
+$275K |
| 5 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
+$202K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Group One Trading
Chicago,
Illinois
|
-$137K |
| 2 |
Millennium Management
New York
|
-$122K |
| 3 |
EDRH
Edmond de Rothschild Holding
Chambesy,
Switzerland
|
-$78K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$74.8K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$49K |
AVXL Hedge Fund Activity: Q1 2019 in Review
56 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in Anavex Life Sciences (AVXL) for Q1 2019, worth a combined $22.5M — up 115% from $10.5M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new AVXL positions and 6 closed out — a net gain of 7 holders — while 13 added to existing stakes and 15 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $508K. The largest seller was Group One Trading, cutting an estimated $137K.
- 56 institutional investors held Anavex Life Sciences (AVXL) as of Q1 2019, up from 49 in Q4 2018.
- Funds reported $22.5M of Anavex Life Sciences stock for Q1 2019, up 115% quarter-over-quarter.
- 13 funds opened new Anavex Life Sciences positions in Q1 2019 and 6 closed out, a net change of +7 holders.
- The largest Anavex Life Sciences buyer in Q1 2019 was Susquehanna International Group, an estimated $508K added.
- The largest Anavex Life Sciences seller in Q1 2019 was Group One Trading, an estimated $137K sold.
Based on aggregated 13F filings for Q1 2019.